(FM) Oncología
Departamento académico
Hospital General Universitario de Alicante
Alicante, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (8)
2020
-
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer, Vol. 18, Núm. 6, pp. 452-460
2019
-
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program
Clinical and Translational Oncology, Vol. 21, Núm. 9, pp. 1270-1279
2017
-
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial
The Lancet Oncology, Vol. 18, Núm. 5, pp. 672-681
2013
-
Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)
Clinical and Translational Oncology, Vol. 15, Núm. 9, pp. 698-704
-
Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study
Lung Cancer, Vol. 81, Núm. 1, pp. 84-90
2011
-
Brain metastases from lung cancer responding to erlotinib: The importance of EGFR mutation
European Respiratory Journal, Vol. 37, Núm. 3, pp. 624-631
2008
-
A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: A GEICO (Grupo Español de Investigación en Cáncer de Ovario) trial
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 31, Núm. 5, pp. 481-487